Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

ClinicalTrials.gov ID: NCT05525520

Public ClinicalTrials.gov record NCT05525520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 6:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase 2 trial will evaluate the effects of EP547 in subjects with cholestatic pruritus due to Primary Biliary Cholangitis (PBC) or Primary Sclerosing Cholangitis (PSC)

Study identification

NCT ID
NCT05525520
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Escient Pharmaceuticals, Inc
Industry
Enrollment
62 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 6, 2022 (Actual)
Primary completion
Jul 17, 2024 (Actual)
Completion
Sep 5, 2024 (Actual)
Last update posted
Jul 31, 2025

2022 – 2024

United States locations

U.S. sites
21
U.S. states
13
U.S. cities
20
Facility City State ZIP Site status
University of Alabama Birmingham Hospital Birmingham Alabama 35294 —
Dignity Health Center for Clinical Research at St. Joseph Hospital Phoenix Arizona 85013 —
Southern California Research Center Coronado California 92118 —
Science 37 Culver City California 90230 —
California Liver Research Institute Pasadena California 91105 —
University of Miami - Schiff Center for Liver Diseases Miami Florida 33136 —
University of Iowa Hospitals & Clinics Iowa City Iowa 52242 —
Tulane University Health Sciences Center New Orleans Louisiana 70112 —
Ochsner Medical Center New Orleans Louisiana 70121 —
Massachusetts General Hospital Boston Massachusetts 02114 —
University of Minnesota Minneapolis Minnesota 55455 —
NYU Grossman School of Medicine Gastroenterology and Hepatology New York New York 10016 —
Montefiore Medical Center The Bronx New York 10467 —
Gastro Health Research Cincinnati Ohio 45249 —
University Hospitals Cleveland Medical Center Cleveland Ohio 44106 —
UPMC Center for Liver Disease Pittsburgh Pennsylvania 15213 —
The Liver Institute at Methodist Dallas Medical Center Dallas Texas 75203 —
Liver Associates of Texas, PA Houston Texas 77030 —
Gastro Health & Nutrition Katy Texas 77494 —
Digestive & Liver Disease Specialists Norfolk Virginia 23502 —
Bon Secours Liver Institute of Virginia Richmond Virginia 23226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05525520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 31, 2025 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05525520 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →